LIN.US

451.26

-0.12%↓

SHW

351.01

-0.43%↓

SCCO

88.37

+0.44%↑

ECL

252.26

-1.26%↓

APD

270.01

+0.86%↑

LIN.US

451.26

-0.12%↓

SHW

351.01

-0.43%↓

SCCO

88.37

+0.44%↑

ECL

252.26

-1.26%↓

APD

270.01

+0.86%↑

LIN.US

451.26

-0.12%↓

SHW

351.01

-0.43%↓

SCCO

88.37

+0.44%↑

ECL

252.26

-1.26%↓

APD

270.01

+0.86%↑

LIN.US

451.26

-0.12%↓

SHW

351.01

-0.43%↓

SCCO

88.37

+0.44%↑

ECL

252.26

-1.26%↓

APD

270.01

+0.86%↑

LIN.US

451.26

-0.12%↓

SHW

351.01

-0.43%↓

SCCO

88.37

+0.44%↑

ECL

252.26

-1.26%↓

APD

270.01

+0.86%↑

Search

Balchem Corp

Abrir

SetorMateriais básicos

164.72 0.59

Visão Geral

Variação de preço das ações

24h

Atual

Mín

163.34

Máximo

166.01

Indicadores-chave

By Trading Economics

Rendimento

3.5M

37M

Vendas

11M

251M

P/E

Médio do Setor

38.725

59.757

EPS

1.22

Rendimento de Dividendos

0.54

Margem de lucro

14.79

Funcionários

1,379

EBITDA

14M

62M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+20.73% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.54%

2.89%

Próximos Ganhos

25 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-24M

5.3B

Abertura anterior

164.13

Fecho anterior

164.72

Sentimento de Notícias

By Acuity

50%

50%

94 / 169 Ranking em Basic materials

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Balchem Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de mai. de 2025, 23:59 UTC

Principais Notícias
Ganhos

Naver 1Q Net Slumps on Higher Costs

8 de mai. de 2025, 23:39 UTC

Ganhos

OCBC 1Q Net Down on Lower Interest Income

8 de mai. de 2025, 23:01 UTC

Ganhos

Macquarie Raises Dividend After 5.5% Rise in Annual Profit -- Update

8 de mai. de 2025, 22:52 UTC

Ganhos

REA Expects Annual Listings Growth Despite April Decline

8 de mai. de 2025, 22:46 UTC

Ganhos

Macquarie Raises Dividend After 5.5% Rise in Annual Profit

8 de mai. de 2025, 23:45 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de mai. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Rise as Tariffs Fears Ease -- Market Talk

8 de mai. de 2025, 23:41 UTC

Conversa de Mercado

Gold Rises on Possible Technical Recovery; Gains May be Capped by Risk-on Mood -- Market Talk

8 de mai. de 2025, 23:30 UTC

Ganhos

Itau Unibanco 1Q Rev BRL45.02B >ITUB

8 de mai. de 2025, 23:29 UTC

Ganhos

Itau Unibanco 1Q EPS BRL1.03 >ITUB

8 de mai. de 2025, 23:22 UTC

Ganhos

Naver 1Q Net Profit Largely Met FactSet-Compiled Consensus

8 de mai. de 2025, 23:22 UTC

Ganhos

Naver 1Q Net KRW423.70B Vs. Net KRW555.80B >035420.SE

8 de mai. de 2025, 23:21 UTC

Ganhos

Naver 1Q Oper Pft KRW505.30B Vs. Pft KRW439.30B >035420.SE

8 de mai. de 2025, 23:21 UTC

Ganhos

Naver 1Q Rev KRW2.787T Vs. KRW2.526T >035420.SE

8 de mai. de 2025, 23:17 UTC

Ganhos

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.35B Vs. S$2.44B >O39.SG

8 de mai. de 2025, 23:17 UTC

Ganhos

Oversea-Chinese Banking Corp. 1Q Total Income S$3.66B Vs. S$3.63B >O39.SG

8 de mai. de 2025, 23:17 UTC

Ganhos

Oversea-Chinese Banking Corp. 1Q Net S$1.88B Vs. Net S$1.98B >O39.SG

8 de mai. de 2025, 23:05 UTC

Conversa de Mercado

ANZ Could Cut Dividend by 10% From 2H -- Market Talk

8 de mai. de 2025, 23:05 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de mai. de 2025, 23:01 UTC

Principais Notícias

With U.K. Deal, U.S. Signals That 10% Tariff on World Is New Baseline -- WSJ

8 de mai. de 2025, 22:28 UTC

Ganhos

REA Expects FY 2025 Listings Growth of 1-2%

8 de mai. de 2025, 22:28 UTC

Ganhos

REA Says April Listings Decline Reflects Year Ago Strength, Timing of Easter and Election

8 de mai. de 2025, 22:27 UTC

Ganhos

REA Says April Sydney, Melbourne Listings Both Down 16% on Year

8 de mai. de 2025, 22:27 UTC

Ganhos

REA Says April Residential Listings Fell by 11% on Year

8 de mai. de 2025, 22:26 UTC

Ganhos

REA 3Q Operating Expenses A$176 Million, Up 12% on Year

8 de mai. de 2025, 22:26 UTC

Ganhos

REA 3Q Free Cash Flow A$132 Million, Up 19% on Year

8 de mai. de 2025, 22:26 UTC

Ganhos

REA 3Q Operating Ebitda A$199 Million, Up 12% on Year

8 de mai. de 2025, 22:26 UTC

Ganhos

REA Nine-Months Free Cash Flow A$389 Million, Up 21% on Year

8 de mai. de 2025, 22:25 UTC

Ganhos

REA Nine-Months Operating Expenses A$513 Million, Up 15% on Year

8 de mai. de 2025, 22:25 UTC

Ganhos

REA Nine-Months Operating Ebitda A$734 Million, Up 19% on Year

Comparação entre Pares

Variação de preço

Balchem Corp Previsão

Preço-alvo

By TipRanks

20.73% parte superior

Previsão para 12 meses

Média 198 USD  20.73%

Máximo 216 USD

Mínimo 180 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Balchem Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

156.59 / 164.38Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

94 / 169 Ranking em Materiais básicos

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Balchem Corp

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.